Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Despite strong financial performance with increased sales and margins, risks such as geopolitical tensions, potential inflation impacts, and challenges in sustaining high growth in China temper the outlook. While the share repurchase program and digital expansion are positive, increased SG&A expenses and reliance on digital transformation pose risks. The Q&A highlighted focus on digital and technology, but lack of clarity on product specifics adds uncertainty. The mixed factors suggest a neutral stock price movement over the next two weeks.
Key Financial Performance
Net Sales $122.9 million, a 9% increase year-over-year (7% increase excluding foreign exchange rates). Growth driven by acceleration in North America, strength in Asia Pacific and Europe, and digital channel expansion.
North America Sales $38.3 million, a 9% increase year-over-year. Digital business grew 42%, driven by customer acquisition and subscription Autoship program adoption.
Asia Pacific Sales $52.2 million, a 7% increase year-over-year (6% growth on a constant currency basis). Growth driven by strong performance in China (40%), Japan (16%), and Korea (14%), supported by subscription Autoship program and independent consultants.
Europe Sales $26.4 million, a 9% increase year-over-year (6% growth on a constant currency basis). Growth driven by improved product availability and strong execution by independent consultants.
Gross Margin 73.2%, an increase of 116 basis points from 72.1% year-over-year. Improvement due to logistics contract renegotiations, manufacturing efficiency, sourcing, pricing, and cost-saving measures.
Operating Income $9.5 million, a 53% increase year-over-year. Growth driven by sales increase and gross margin improvement.
Adjusted EBITDA $14.6 million, a 33% increase year-over-year. Growth driven by sales increase and gross margin improvement.
Net Income $5.1 million, compared to $4.7 million year-over-year. Growth attributed to sales and operational improvements.
Cash and Cash Equivalents $87.6 million, with no debt. Reflects a strong balance sheet.
Inventory $67.1 million, a $1.2 million decrease from Q4 2025. Reflects efforts to maintain appropriate in-stock levels.
Net Cash Used by Operating Activities $1.8 million, compared to cash provided of $2.6 million year-over-year. Reflects operational cash flow changes.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
L'amara skin care products: Successfully launched in Japan and Korea, contributing to double-digit growth in these markets.
Digital channel expansion: Rapid growth in North America with a 42% increase in digital business and 60% growth in new digital customers in Q1.
Subscription Autoship program: Strong adoption globally, accounting for 48% of digital sales in North America and 25% of total revenue in China.
Social commerce: Triple-digit growth year-over-year, with subscription Autoship making up 23% of total social commerce revenue.
Geographic expansion: Plans to enter Germany, the largest supplement market in Europe, and expand into new Asian markets.
Gross margin improvement: Increased to 73.2% from 72.1% due to better manufacturing efficiency, sourcing, and pricing strategies.
SG&A expenses: Increased to $43.5 million, primarily due to variable costs and compensation, but reduced as a percentage of net sales.
Inventory management: Decreased to $67.1 million, with plans for moderate increases to meet demand.
Vision for Growth: Aiming to double sales to $1 billion and achieve a 15% EBITDA margin through digital expansion, market penetration, and product innovation.
Synergy brand expansion: Doubling down on U.S. distribution as a key growth driver.
Supply chain efficiency: Investing in automation and leveraging manufacturing capacity for higher margins.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Geopolitical tensions in Iran: Potential impact on inflation and short-term consumer buying patterns, which could affect demand and costs.
China market growth sustainability: The 40% growth in China seen in Q1 is unlikely to be repeated in the coming quarters, indicating potential challenges in maintaining such high growth rates.
War in Eastern Europe: Continued conflict in the region poses risks to economic stability and could impact growth projections.
SG&A expenses increase: Expected increase in SG&A expenses to $45-$47 million per quarter for the remainder of the year due to strategic investments, which could temporarily reduce EBITDA growth rates.
Short-term inflation uncertainty: Uncertainty regarding the impact of the Iran situation on inflation could affect gross margins and overall financial performance.
Dependence on digital transformation: Heavy reliance on digital transformation and subscription models for growth, which may pose risks if adoption rates or customer retention falter.
Expansion into new markets: Entering new markets like Germany and other Asian regions involves risks related to market penetration, competition, and execution.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: The company expects full-year 2026 net sales to range between $500 million and $515 million, representing year-over-year growth of 4% to 7%. Continued mid- to high single-digit revenue growth is anticipated in North America throughout 2026. Europe is expected to see mid-single-digit growth for the remainder of 2026.
Adjusted EBITDA: Guidance for adjusted EBITDA is set at $50 million to $54 million for 2026, reflecting year-over-year growth of 1% to 9%. Temporary reductions in EBITDA growth rates are expected in Q2 and Q3 due to strategic investments.
Gross Margin: Gross margins are expected to average around 73% during 2026, reflecting ongoing improvements in cost-saving measures and favorable market mix.
Strategic Investments: The company plans measured investments in technology infrastructure, customer acquisition, geographic expansion, market penetration, and product innovation during 2026, with a focus on positioning for sustained growth in 2027 and beyond.
Market Expansion: Plans to enter Germany, the largest supplement market in Europe, in 2026. Future expansion into new Asian markets is also planned, leveraging the Synergy Asia sales system.
Product Innovation: A strong new product pipeline is planned over the next two years, with details to be shared closer to launch dates.
Digital Business Growth: Continued rapid expansion of the digital business is expected, with subscription models driving recurring revenue streams. Social commerce is also expected to grow significantly.
China Market: While Q1 2026 saw 40% growth in China, this level of growth is not expected to continue in subsequent quarters. However, strong fundamentals and adoption of subscription programs are expected to support continued growth.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Program: We repurchased 20,000 shares for approximately $0.5 million or $24.54 per share during the first quarter ended March 31, 2026, with $16.9 million remaining on our share repurchase program.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you talk about the 15% EBITDA margin longer term and the building blocks to achieve it?
A:The management explained that achieving the 15% EBITDA margin involves scale through volume growth and cost discipline. Shane Jones provided specifics, stating that 1 point will come from gross margin improvements through manufacturing efficiency, 2 points from reducing volume incentives driven by digital business growth, and 2 points from leveraging SG&A as the company grows.
Q:Does the appointment of a new Chief Technology Officer signal a continued focus on digital and DTC expansion?
A:Yes, the hiring of a CTO is aimed at enhancing technology across the company, including evolving the ERP system, driving digital growth, utilizing AI, and enabling independent consultants with tools like a new app. Investments in technology are a key focus this year, impacting EBITDA growth.
Q:Can you provide some color on the brands and products driving growth in each region and plans for new products?
A:Nature's Sunshine is driving growth in the U.S., Latin America, Europe, and China, while Synergy is driving growth in Korea, Taiwan, Japan, and Southeast Asia. The company is planning a pan-Asian product launch in Korea, Japan, and Taiwan, but specifics on new products were not disclosed.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details about new products, stating they would disclose them closer to the launch date. Additionally, while discussing the pan-Asian product launch, they did not reveal the product's specifics, only mentioning it as a first-time initiative.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Administrative percentage
America Asia
America currency
America expansion
America strength
CEO Romanzi
CFO detail
China adoption
China digit
Europe Latin
Europe tension
Executive VP
Form Executive
Iran inflation
Japan Korea
Nature Sunshine
Vision
ability
adoption subscription
channel
commerce
consultant globe
currency term
customer acquisition
effort
engagement
increase consultant
increase sale
market product
momentum sale
progress
remainder
stock level
subscription program
NATR Transcript
Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript
Unknown5-7
Despite strong financial performance with increased sales and margins, risks such as geopolitical tensions, potential inflation impacts, and challenges in sustaining high growth in China temper the outlook. While the share repurchase program and digital expansion are positive, increased SG&A expenses and reliance on digital transformation pose risks. The Q&A highlighted focus on digital and technology, but lack of clarity on product specifics adds uncertainty. The mixed factors suggest a neutral stock price movement over the next two weeks.
Bicara Therapeutics Inc. (BCAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
CACI International Inc (CACI) Presents at 2026 Cantor Global Technology & Industrial Growth Conference Transcript
Neutral3-10
Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript
Positive3-10
The earnings call reveals strong financial performance with a notable increase in net income and adjusted EBITDA. Despite some challenges in Asia, growth in North America and Europe is robust. The company's digital transformation and strategic use of TikTok for customer acquisition are promising. While there are uncertainties regarding EBITDA outcomes for 2026, the overall outlook remains positive, supported by a strong balance sheet with no debt. The lack of specific guidance on revenue goals is a minor concern, but it doesn't overshadow the positive aspects.
NATR Slides
NATR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
